Th17 cell response in SOD1G93A mice following motor nerve injury

Mediators of Inflammation

Volumn 2016, Issue , 2016, Pages

  Ni, Allen ^a,b   Yang, Tao ^c   Mesnard Hoaglin, Nichole A ^b   Gutierrez, Rafael ^a   Stubbs, Evan B ^b,d   McGuire, Susan O ^b   Sanders, Virginia M ^e   Jones, Kathryn J ^f,g   Foecking, Eileen M ^b,h   Xin, Junping ^a,b  

^a LOYOLA UNIVERSITY CHICAGO   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c Gansu Province Hospital of Traditional Chinese Medicine   (China)

^d LOYOLA UNIVERSITY CHICAGO   (United States)

^e THE OHIO STATE UNIVERSITY COLLEGE OF MEDICINE   (United States)

^f INDIANA UNIVERSITY   (United States)

^g RICHARD L ROUDEBUSH VETERANS AFFAIRS MEDICAL CENTER   (United States)

^h LOYOLA UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYOTROPHIC LATERAL SCLEROSIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CD4+ T LYMPHOCYTE; CONTROLLED STUDY; FACIAL NERVE INJURY; FEMALE; GENETIC SUSCEPTIBILITY; HETEROZYGOTE; IMMUNE RESPONSE; IMMUNOCOMPETENT CELL; LYMPHOCYTE ACTIVATION; MOTOR NERVE; MOUSE; NERVE FIBER TRANSECTION; NEUROLOGIC DISEASE; NONHUMAN; TH17 CELL; TRANSGENIC MOUSE; ANIMAL; DISEASE MODEL; GENETICS; IMMUNOLOGY; LYMPHOCYTOPENIA; METABOLISM; MOTONEURON; PATHOLOGY;

COPPER ZINC SUPEROXIDE DISMUTASE; SOD1 PROTEIN, MOUSE;

ANIMALS; DISEASE MODELS, ANIMAL; FACIAL NERVE INJURIES; FEMALE; MICE; MICE, TRANSGENIC; MOTOR NEURONS; SUPEROXIDE DISMUTASE-1; T-LYMPHOCYTOPENIA, IDIOPATHIC CD4-POSITIVE; TH17 CELLS;

EID: 84973473379     PISSN: 09629351     EISSN: 14661861     Source Type: Journal    
DOI: 10.1155/2016/6131234     Document Type: Article

References (16)

1. N. Scarmeas, T. Shih, Y. Stern, R. Ottman, and L. P. Rowland, "Premorbid weight, body mass, and varsity athletics in ALS, " Neurology, vol. 59, no. 5, pp. 773-775, 2002.
2. A. Chio, G. Benzi, M. Dossena, R. Mutani, and G. Mora, "Severely increased risk of amyotrophic lateral sclerosis among Italian professional football players, " Brain, vol. 128, part 3, pp. 472-476, 2005.
3. R. D. Horner, K. G. Kamins, J. R. Feussner et al., "Occurrence of amyotrophic lateral sclerosis among Gulf War veterans, " Neurology, vol. 61, no. 6, pp. 742-749, 2003.
4. N. A.Mesnard-Hoaglin, J. Xin, M. M. Haulcomb, R. J. Batka, V. M. Sanders, andK. J. Jones, "SOD1G93A transgenic mouse CD4+ T cells mediate neuroprotection after facial nerve axotomy when removed from a suppressive peripheral microenvironment, " Brain, Behavior, and Immunity, vol. 40, pp. 55-60, 2014.
5. M. Bowerman, T. Vincent, F. Scamps, F. E. Perrin, W. Camu, and C. Raoul, "Neuroimmunity dynamics and the development of therapeutic strategies for amyotrophic lateral sclerosis, " Frontiers in Cellular Neuroscience, vol. 7, article 214, 2013.
6. M. C. O. Rodrigues, J. C. Voltarelli, P. R. Sanberg, C. V. Borlongan, and S. Garbuzova-Davis, "Immunological aspects in amyotrophic lateral sclerosis, " Translational Stroke Research, vol. 3, no. 3, pp. 331-340, 2012.
7. M. Rentzos, A. Rombos, C. Nikolaou et al., "Interleukin-17 and interleukin-23 are elevated in serum and cerebrospinal fluid of patients with ALS: a reflection of Th17 cells activation?" Acta Neurologica Scandinavica, vol. 122, no. 6, pp. 425-429, 2010.
8. M. Fiala, M. Chattopadhay, A. La Cava et al., "IL-17A is increased in the serumand in spinal cord CD8 and mast cells of ALS patients, " Journal of Neuroinflammation, vol. 7, article 76, 2010.
9. C. Moreau, D. Devos, V. Brunaud-Danel et al., "Elevated IL-6 and TNF-α levels in patients with ALS: inflammation or hypoxia?" Neurology, vol. 65, no. 12, pp. 1958-1960, 2005.
10. J. S. Henkel, D. R. Beers, S. Wen et al., "Regulatory T-lymphocytes mediate amyotrophic lateral sclerosis progression and survival, " EMBO Molecular Medicine, vol. 5, no. 1, pp. 64-79, 2013.
11. W. Zhao, D. R. Beers, B. Liao, J. S. Henkel, and S. H. Appel, "Regulatory T lymphocytes from ALS mice suppress microglia and effector T lymphocytes through different cytokine-mediated mechanisms, " Neurobiology of Disease, vol. 48, no. 3, pp. 418-428, 2012.
12. J. Xin, D. A. Wainwright, C. J. Serpe, V. M. Sanders, and K. J. Jones, "Phenotype of CD4+ T cell subsets that develop following mouse facial nerve axotomy, " Brain, Behavior, and Immunity, vol. 22, no. 4, pp. 528-537, 2008.
13. R. Banerjee, R. L. Mosley, A. D. Reynolds et al., "Adaptive immune neuroprotection in G93A-SOD1 amyotrophic lateral sclerosis mice, " PLoS ONE, vol. 3, no. 7, Article ID e2740, 2008.
14. I. M. Chiu, A. Chen, Y. Zheng et al., "T lymphocytes potentiate endogenous neuroprotective inflammation in a mouse model of ALS, " Proceedings of the National Academy of Sciences of the United States of America, vol. 105, no. 46, pp. 17913-17918, 2008.
15. M. S. Maddur, P. Miossec, S. V. Kaveri, and J. Bayry, "Th17 cells: biology, pathogenesis of autoimmune and inflammatory diseases, and therapeutic strategies, " American Journal of Pathology, vol. 181, no. 1, pp. 8-18, 2012.
16. J. Xin, D. A. Wainwright, N. A. Mesnard, C. J. Serpe, V. M. Sanders, and K. J. Jones, "IL-10 within the CNS is necessary for CD4+ T cells to mediate neuroprotection, " Brain, Behavior, and Immunity, vol. 25, no. 5, pp. 820-829, 2011.